Abstract
Purpose
To evaluate the impact of a multidisciplinary the “Endocarditis Team” (ET) on the course and outcome of infective endocarditis (IE) patients.
Methods
A retrospective before–after study, including hospitalized patients with definite IE, managed before (01.2013–12.2015) and after (01.2016–07.2019) the introduction of an ET. The primary outcomes were defined as 30-day and 1-year mortality and the secondary as conservative vs. invasive strategy, the interval from clinical suspicion of IE to the performance of echocardiography, utilization of multimodality evaluation, time to an invasive procedure, and the duration of hospitalization.
Results
Study population included 92 pre-ET and 128 post-ET implementation patients. Baseline characteristics were similar. During the post-ET period compared with pre-ET, we found higher rates of abscesses and extra-cardiac emboli (27.8% vs. 16.3%, p = 0.048); and a higher invasive procedures rate, including lead extraction (15.6% vs. 6.5%, p = 0.035) and noncardiac surgeries (14.8% vs. 6.5%, p = 0.05). Patients managed during the post-ET period had reduced short (8.5% vs. 17.4%, p = 0.048) and long-term mortality (Log-rank = 0.001). In multivariate analysis of risk factors for long-term mortality, period (pre- or post-ET) was not found to be significantly associated with the mortality.
Conclusion
Establishment of an ET was associated with faster and more intensive evaluation of patients with IE. During the period of an ET activity, mortality rates were reduced compared with the previous period.
Similar content being viewed by others
Abbreviations
- CIED:
-
Cardiac implanted electronic devices
- ET:
-
Endocarditis team
- IE:
-
Infective endocarditis
- F18 :
-
FDG PET CT−8F-fluorodeoxyglucose positron emission tomography/computed tomography
- TOE:
-
Transesophageal echocardiography
- TTE:
-
Transthoracic echocardiography
References
Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, Hirsch GA, Mehta JL. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6. https://doi.org/10.1016/j.jacc.2015.03.518.
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F, for the Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81. https://doi.org/10.1001/jama.288.1.75.
Murdoch D, Corey G, Hoen B, Miró J, Fowler VG Jr, Bayer A, Karchmer AW, Lars O, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169:463. https://doi.org/10.1001/archinternmed.2008.603.
Baddour L, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O’Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation. 2015;132:1435–86. https://doi.org/10.1161/CIR.0000000000000296.
Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana JM, Vidal B, Almela M, Quintana E, Llopis J, Moreno A, Miro JM, Hospital Clinic Infective Endocarditis Investigators. The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep. 2017;19:21. https://doi.org/10.1007/s11908-017-0574-9.
Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590–1. https://doi.org/10.1016/j.jacc.2006.05.016 (Epub 2006 Jul 12).
Amat-Santos I, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutiérrez-Ibanes E, Munoz-Garcia AJ, Pan M, Webb JG, Herrmann HC, Kodali S, Nombela-Franco L, Tamburino C, Jilaihawi H, Masson JB, de Brito FS Jr, Ferreira MC, Lima VC, Mangione JA, Iung B, Vahanian A, Durand E, Tuzcu EM, Hayek SS, Angulo-Llanos R, Gómez-Doblas JJ, Castillo JC, Dvir D, Leon MB, Garcia E, Cobiella J, Vilacosta I, Barbanti M, Makkar R, Ribeiro HB, Urena M, Dumont E, Pibarot P, Lopez J, San Roman A, Rodés-Cabau J. Infective endocarditis after transcatheter aortic valve implantation. Circulation. 2015;131:1566–74. https://doi.org/10.1161/CIRCULATIONAHA.114.014089.
Habib G, Derumeaux G, Avierinos J, Casalta JP, Jamal F, Volot F, Garcia M, Lefevre J, Biou F, Maximovitch-Rodaminoff A, Fournier PE, Ambrosi P, Velut JG, Cribier A, Harle JR, Weiller PJ, Raoult D, Luccioni R. Value and limitations of the duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023–9. https://doi.org/10.1016/s0735-1097(99)00116-3.
Vieira M, Grinberg M, Pomerantzeff P, Andrade J, Mansur A. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart. 2004;90:1020–4. https://doi.org/10.1136/hrt.2003.025585.
Wang A, Gaca J, Chu V. Management considerations in infective endocarditis. JAMA. 2018;320:72. https://doi.org/10.1001/jama.2018.7596.
Habib G, Lancellotti P, Antunes M, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075–128. https://doi.org/10.1093/eurheartj/ehv319.
Baddour LM, Wilson W, Bayer A, Fowler V, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O’Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. J Circulation. 2015;132:1435–86. https://doi.org/10.1161/CIR.0000000000000296.
Mangner N, Linke A. Infective valve endocarditis after transcatheter aortic valve implantation—a dangerous liaison. Ann Cardiothorac Surg. 2019;8:685–7. https://doi.org/10.21037/acs.2019.06.03.
Chourdakis E, Koniari I, Hahalis G, Kounis NG, Hauptmann KE. Endocarditis after transcatheter aortic valve implantation: a current assessment. J Geriatr Cardiol. 2018;15(1):61–5. https://doi.org/10.11909/j.issn.1671-5411.2018.01.003.
Botelho-Nevers E, Thuny F, Casalta J, Richet H, Gouriet F, Collart F. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Inter Med. 2009;169:1290. https://doi.org/10.1001/archinternmed.2009.192.
Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A, De Leo A, Minniti G, Polesel E, Olivari Z. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol. 2013;112:1171–6. https://doi.org/10.1016/j.amjcard.2013.05.060.
Camou F, Dijos M, Barandon L, Cornolle C, Greib C, Laine M, Lecomte R, Boutoille D, Machelart I, Peuchant O, Tlili G, Wirth G, Issa N. Management of infective endocarditis and multidisciplinary approach. Méd Mal Infect. 2019;49:17–22. https://doi.org/10.1016/j.medmal.2018.06.007.
Carrasco-Chinchilla F, Sánchez-Espín G, Ruiz-Morales J, Rodríguez-Bailón I, Melero-Tejedor J, Ivanova-Georgieva R, García-López V, Muñoz-García A, Gómez-Doblas JJ, de Teresa-Galván E. Influence of a multidisciplinary alert strategy on mortality due to left-sided infective endocarditis. Rev Esp Cardiol. 2014;67:380–6. https://doi.org/10.1016/j.rec.2013.09.010.
Davierwala P, Marin-Cuartas M, Misfeld M, Borger M. The value of an “Endocarditis Team.” Ann Cardiothorac Surg. 2019;8:621–9. https://doi.org/10.21037/acs.2019.09.03.
Ruch Y, Mazzucotelli J, Lefebvre F, Martin A, Lefebvre N, Douiri N, Riegel P, Hoang Minh T, Petit-Eisenmann H, Hansmann Y, Argemi X. Impact of setting up an “Endocarditis Team” on the management of infective endocarditis. Open Forum Infect Dis. 2019. https://doi.org/10.1093/ofid/ofz3.
Kaura A, Byrne J, Fife A, Deshpande R, Baghai M, Gunning M, Whitaker D, Monaghan M, MacCarthy PA, Wendler O, Dworakowski R. Inception of the ‘endocarditis team’ is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study. Open Heart. 2017;4:e000699. https://doi.org/10.1016/0002-9343(94)90143-0.
San S, Ravis E, Tessonier L, Philip M, Cammilleri S, Lavagna F, Norscini G, Arregle F, Martel H, Oliver L, Torras O, Renard S, Ambrosi P, Camoin L, Casalta AC, Hubert S, Casalta JP, Gouriet F, Riberi A, Avierinos JF, Lepidi H, Collart F, Raoult D, Drancourt M, Habib G. Prognostic value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in infective endocarditis. J Am Coll Cardiol. 2019;74:1031–40. https://doi.org/10.1016/j.jacc.2019.06.050.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Elad, B., Perl, L., Hamdan, A. et al. The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy. Infection 50, 57–64 (2022). https://doi.org/10.1007/s15010-021-01636-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-021-01636-3